If you are wondering whether AstraZeneca's share price still offers value or is starting to look expensive, the next sections will walk through what the current market price might be implying.

Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be ...

AstraZeneca's ambitious $80 billion revenue goal by 2030 hinges on oncology growth and successful new drug launches, but faces patent expiries and fierce competition. While current financials and ...

SALT LAKE CITY — The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general, claiming Utah's new law on limiting prescription drug prices goes against a federal ...

AstraZeneca has succumbed to pressure from US president Donald Trump to reduce the cost of its medications for American patients. The Cambridge-headquartered pharmaceutical giant announced it will ...